Filing Details
- Accession Number:
- 0001127602-19-019121
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-05-20 14:05:57
- Reporting Period:
- 2019-05-16
- Accepted Time:
- 2019-05-20 14:05:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 794172 | Meridian Bioscience Inc | VIVO | In Vitro & In Vivo Diagnostic Substances (2835) | 310888197 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1468718 | M. James Anderson | 3471 River Hills Drive Cincinnati OH 45244 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-05-16 | 981 | $0.00 | 0 | No | 4 | J | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 981 | $0.00 | 6,981 | No | 4 | J | Direct | |
| Common Stock | Acquisiton | 2019-05-16 | 5,000 | $11.37 | 11,981 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | J | Direct | |
| No | 4 | J | Direct | |
| No | 4 | P | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 5,000 | Indirect | By Spouse |
Footnotes
- Following the January 24, 2019 grant of 981 restricted stock units (as reported on Form 4 filed January 28, 2019), Direct Common Stock holdings totaled 6,981.
- Prices range from $11.3350 per share to $11.4300 per share. The reporting person undertakes to provide full pricing information if requested by the Securities and Exchange Commission, the issuer or a security holder of the issuer.
Billionaire Hedge Funds
